AUROBINDO PHARMA
|
AUROBINDO PHARMA Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹5,066 Cr | ₹4,380 Cr | ₹2,613 Cr | ₹3,373 Cr | ₹7,344 Cr |
| Adjustment | ₹1,834 Cr | ₹1,496 Cr | ₹1,586 Cr | ₹1,344 Cr | ₹-1,663 Cr |
| Changes In working Capital | ₹-1,244 Cr | ₹-1,675 Cr | ₹-1,095 Cr | ₹1,558 Cr | ₹-1,067 Cr |
| Cash Flow after changes in Working Capital | ₹5,656 Cr | ₹4,201 Cr | ₹3,104 Cr | ₹6,275 Cr | ₹4,614 Cr |
| Cash Flow from Operating Activities | ₹3,925 Cr | ₹2,435 Cr | ₹2,387 Cr | ₹5,016 Cr | ₹3,329 Cr |
| Cash Flow from Investing Activities | ₹-1,876 Cr | ₹-4,256 Cr | ₹-3,978 Cr | ₹-3,212 Cr | ₹599 Cr |
| Cash Flow from Financing Activities | ₹120 Cr | ₹800 Cr | ₹1,814 Cr | ₹-2,969 Cr | ₹-1,365 Cr |
| Net Cash Inflow / Outflow | ₹2,169 Cr | ₹-1,021 Cr | ₹223 Cr | ₹-1,164 Cr | ₹2,563 Cr |
| Opening Cash & Cash Equivalents | ₹3,385 Cr | ₹4,392 Cr | ₹4,163 Cr | ₹5,330 Cr | ₹2,747 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | ₹0.66 Cr | - | ₹6.41 Cr | ₹-3.25 Cr | ₹22 Cr |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
| Effect of Foreign Exchange Fluctuations | ₹9.10 Cr | ₹14 Cr | ₹-0.06 Cr | ₹0.20 Cr | ₹-2.12 Cr |
| Closing Cash & Cash Equivalent | ₹5,564 Cr | ₹3,385 Cr | ₹4,392 Cr | ₹4,163 Cr | ₹5,330 Cr |
Compare Cashflow Statement of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹86,960.2 Cr | 1.7% | 9.9% | 25.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,075.0 Cr | 0.4% | 10.8% | 10.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,486.0 Cr | 0.7% | 9.5% | 16.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,124.0 Cr | -2.5% | 6% | 36.2% | Stock Analytics | |
| CIPLA | ₹115,641.0 Cr | 9.7% | 16.7% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,589.0 Cr | 4.5% | 9.7% | 9% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | 1.7% |
9.9% |
25.2% |
| SENSEX | -2.7% |
-2.1% |
-5.3% |
You may also like the below Video Courses